WhaleWatchWhaleWatch
Smart Money Alert
Onesource Specialty Pharma Limited logo

Onesource Specialty Pharma Limited

New PositionQuarterly
ONESOURCEPharmaceuticalsMarket Cap₹18K Cr
Stake
1.76%
Fidelity
Fidelity
Foreign Investor
The move

Fidelity bought 20,20,423 shares of Onesource Specialty Pharma Limited, a 1.76% stake, worth ₹334.02 Cr at ₹1653.20 apiece.

About Onesource Specialty Pharma Limited
Visit stock

A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.

About Fidelity
Visit investor

Boston-based global active asset manager with India exposure through emerging market and India-focused funds.

Get the next move the moment it happens.
Follow Fidelity and Onesource Specialty Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Onesource Specialty Pharma Limited shareholdersFidelity's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Onesource Specialty Pharma Limited
More moves in Onesource Specialty Pharma Limited
Amansa HoldingsDecreased
Amansa Holdings decreased its stake in Onesource Specialty Pharma Limited from 3.47% to 1.86%, selling 1,841,289 shares. The value of the remaining shares is ₹334.8 Cr at ₹1571.30 apiece.
22 Jul 2026
Read more
SBI Life InsuranceDecreased
SBI Life Insurance decreased its stake in Onesource Specialty Pharma Limited from 2.53% to 2.06% by selling 535,750 shares. The shares are valued at ₹84.22 crore, calculated at a share price of ₹1571.30.
22 Jul 2026
Read more
Axis Mutual FundDecreased
Axis Mutual Fund decreased its stake in Onesource Specialty Pharma Limited from 1.47% to 1.33% by selling 155,669 shares. The value of the shares sold is ₹24.43 crore at ₹1571.30 apiece.
22 Jul 2026
Read more
Authum Investment & InfrastructureDecreased
Authum Investment & Infrastructure reduced its stake in Onesource Specialty Pharma Limited from 5.16% to 4.96% by decreasing its shareholding from 5,909,646 to 5,681,844 shares. This involved selling 227,802 shares for ₹35.75 crore at ₹1571.30 apiece, crossing the 5% disclosure threshold.
22 Jul 2026
Read more
Timf HoldingsDecreased
Timf Holdings decreased its stake in Onesource Specialty Pharma Limited from 2.20% to 1.26%, selling 1,077,044 shares. The value of the shares sold is ₹169.25 crore at a price of ₹1571.30 per share.
22 Jul 2026
Read more
See all moves
Fidelity
More moves by Fidelity
Computer Age Management Services Limited
Direction, size, price and stake change for this move, with what it means for the company.
10 Sept 2026. Sign in to see this move
Computer Age Management Services Limited
Direction, size, price and stake change for this move, with what it means for the company.
10 Sept 2026. Sign in to see this move
Computer Age Management Services Limited
Direction, size, price and stake change for this move, with what it means for the company.
10 Sept 2026. Sign in to see this move
Meesho LimitedNew position
Fidelity bought 3,31,100 shares of Meesho Limited for ₹6.83 Cr at ₹206.30 apiece in a block deal.
MEESHO3 Sept 2026
Read more
Meesho LimitedNew position
Fidelity bought 18.56 lakh shares of Meesho Limited for ₹38.29 Cr at ₹206.30 apiece in a block deal.
MEESHO3 Sept 2026
Read more
See all moves